21 – 30 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast –long term prognostic significant
- Contribution to journal › Article
-
Mark
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
- Contribution to journal › Article
- 2019
-
Mark
Impact of systemic therapy on circulating leukocyte populations in patients with metastatic breast cancer
- Contribution to journal › Article
- 2018
-
Mark
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
- Contribution to journal › Article
- 2017
-
Mark
Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
- Contribution to journal › Article
- 2016
-
Mark
Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
- Contribution to journal › Article
- 2015
-
Mark
A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
- Contribution to journal › Article
-
Mark
Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
- Contribution to journal › Article
-
Mark
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
- Contribution to journal › Article
- 2014
-
Mark
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
- Contribution to journal › Article
